After showing weakness at the beginning of the week, benchmark stock indexes made steady gains even as economic recovery gathered steam. On
Pfizer Inc.
-(PFE)
Get the latest Pfizer Inc. (PFE) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Pfizer, Inc. (PFE) Q1 2021 Earnings Call Transcript
Pfizer, Inc. (NYSE: PFE) Q1 2021 earnings call dated May. 04, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Pfizer (PFE) reports Q1 EPS of 93 cents: Infographic
Pfizer (NYSE: PFE) reported first-quarter 2021 financial results ahead of the regular market hours on Tuesday. The pharmaceutical giant reported Q1 revenue
Earnings calendar for the week of May 3
Leading stock indexes retreated after gaining mid-week when Wall Street biggies like Apple and Amazon reported impressive quarterly numbers. The Dow Jones
Two areas that provide Pfizer (PFE) with ample opportunity for future growth
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront of the
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete
These two factors will play out in favor of Pfizer (PFE) going forward
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past 12 months. The company had a huge win with
Pfizer Inc. (PFE) Q4 2020 Earnings Call
Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano — Senior Vice President, Investor Relations Albert Bourla — Chairman
Pfizer Inc. (PFE) Q4 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor Relations Albert
Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On a GAAP
Where do these companies stand in the COVID-19 vaccine race?
After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19 is the
Earnings calendar for the week of February 1
In a week that saw one of the worst stock selloffs, Gamestop came under spotlight after the stock experienced unprecedented fluctuations, marked
Is it time to book profits from Moderna?
Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the potential of
COVID-19 vaccine: These pharma companies have also made headway
The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for the development
Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days
Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial of their
COVID-19 vaccine: Pfizer (PFE) and Moderna (MRNA) are ahead in the race, where are the others?
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
Earnings calendar for the week of Nov. 16
Taking cues from the election verdict and positive data from Pfizer's COVID vaccine trial, major Wall Street indexes made strong gains early
Pfizer (PFE) gains on data showing 90% efficacy for COVID-19 vaccine candidate
Shares of Pfizer Inc. (NYSE: PFE) rallied on Monday after the company reported positive results from its Phase 3 trial for its
Pfizer Inc (PFE) Q3 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q3 2020 Earnings Call dated Oct. 27, 2020. Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman
Pfizer (PFE) posts mixed results in Q3
Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 4% decline
COVID-19 vaccine development: A look at some of the pharma companies and their progress
The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict lockdown, things